1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Xiangdong Cheng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer Tislelizumab, SOX or CAPOX regimen - Gastric Cancer Stage | Phase 3 | Not yet recruiting | Xiangdong Cheng | 470 | 2025-07-20 | 2025-07-16 |
XELOX (1) · tislelizumab (1)
China (1)